TGA approval for the TD 100 automated transesophageal echocardiogram (TEE/TOE) probe disinfector and TD-8 OPA based high level disinfectant

CS Medical, LLC has announced the receipt of TGA approval for the TD 100 automated transesophageal echocardiogram (TEE/TOE) probe disinfector and TD-8 OPA based high-level disinfectant. The TD 100 with TD-8 provides high-level disinfection of TEE/TOE probes in 5 minutes and provide a validated method for TEE/TOE reprocessing between patient use.

"We are extremely excited to become the first TEE/TOE automated probe disinfector to have medical device clearances in North America, Europe and Australia,” said Mark Leath, CS Medical President, in the statement.

The advantages of automated reprocessing, which North American customers’ have seen for over ten years, can now be experienced in Australia. This will provide healthcare professionals confidence in the reprocessing of TEE/TOE probes."

In developing the TD 100, CS Medical pioneered the automated disinfection process for TEE/TOE probes. The TD 100 established the first FDA cleared TEE/TOE ultrasound probe automated disinfection process with printed verification and now is the first TEE/TOE probe automated disinfector to have cleared FDA, Directive 93/42/EEC and TGA respectively.

During the disinfection process, the TEE/TOE probe completes high-level disinfection in five minutes, followed by five complete rinse cycles before disinfection confirmation is acknowledged and a report is printed. The TD 100 automated TEE/TOE probe disinfector eliminates manual reprocessing of delicate and expensive TEE/TOE ultrasound probes while providing a repeatable and validated disinfection process.